Jinxin Fertility Group Limited (abbreviation: JXR) has issued its circular for the 2026 annual general meeting (AGM), outlining key resolutions requiring shareholder approval on 25 June 2026 in Chengdu.

Key AGM Proposals 1. Board Composition • Re-election of four retiring directors:  – Executive Director: Dr. Geng Lihong  – Non-executive Director: Ms. Yan Xiaoqing  – Independent Non-executive Directors: Dr. Chong Yat Keung and Mr. Wang Xiaobo

2. Share Issue Mandate • Directors may allot and issue new shares (including disposal of treasury shares) up to 20% of issued share capital, equivalent to a maximum of 533.99 million shares, based on 2.71 billion issued shares (35.05 million held in treasury) as of 26 May 2026. • An additional 10% extension is available to the extent of shares repurchased under the mandate below.

3. Share Repurchase Mandate • Authorises repurchase of up to 10% of issued shares, or 267.00 million shares. • Shares repurchased may be cancelled or held as treasury shares, with subsequent sales or transfers subject to Listing Rules.

4. Final Dividend • Proposed cash dividend of HK$0.0418 per share for FY 2025. • Books close 2–7 July 2026; ex-dividend date 1 July 2026; dividend payable on or before 28 July 2026 to shareholders on record as of 7 July 2026.

5. Auditor Re-appointment • Deloitte Touche Tohmatsu nominated to continue as external auditor for FY 2026. • Audit and related service fees estimated at RMB4.36–5.15 million.

Administrative Details • Proxy forms must reach Computershare Hong Kong Investor Services by 9 a.m. on 23 June 2026. • All resolutions will be decided by poll; holders of treasury shares have no voting rights.

Shareholders are encouraged to review the circular in full and submit proxies in accordance with the stated timeline.